Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Cocrystal Pharma Q2 EPS $(0.25) Down From $(0.04) YoY

Cocrystal Pharma Q2 EPS $(0.25) Down From $(0.04) YoY

Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.25) per share. This is a 525 percent decrease over losses of $(0.04) per share from the same period last year.

byBenzinga Newsdesk

August 15, 2022

1 minute read

Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.25) per share. This is a 525 percent decrease over losses of $(0.04) per share from the same period last year.

Earnings

Bragg Gaming Group’s Earnings: A Preview

By Benzinga Insights

May 9, 2:03 PM

Bragg Gaming Group (NASDAQ:BRAG) is set to give its latest quarterly earnings report on Wednesday, 2023-05-10. Here’s what…

BRAG

News

NFL-Apple Sunday Ticket Talks Threaten To Stretch Into New Year

By Benzinga Newsdesk

December 16, 3:13 PM

https://www.sportico.com/business/media/2022/nfl-sunday-ticket-talks-apple-1234698625/

AAPL

A Q4 Earnings Tale: Will Robinhood Investors Be Rewarded With Riches Or Continue To Suffer From Stock’s Poor Performance?

By Adam Eckert

February 8, 1:13 PM

Robinhood Markets Inc (NASDAQ: HOOD) is set to report fourth-quarter results after the bell Wednesday. The stock is up nearly 30% year-to-date heading into the print. Here's a look at what to expect after the close.

HOOD